AI Integration And Full Risk Contracts Will Boost Efficiency And Patient Outcomes

Shared on30 Apr 25
Fair value Decreased 18%

Shared on23 Apr 25
Fair value Increased 0.091%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Increased 7.95%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25
Fair value Increased 17%

AnalystConsensusTarget has increased future PE multiple from 22.2x to 25.0x.

Shared on11 Mar 25
Fair value Decreased 8.12%

AnalystConsensusTarget has decreased revenue growth from 24.0% to 20.8% and decreased future PE multiple from 31.7x to 22.2x.